Intellia Therapeutics (NTLA) PT Lowered to $44 at Baird
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $11.60 -4.05%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Baird analyst Jack Allen lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $44.00 (from $48.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $42 at Mizuho
- Motorcar Parts of America (MPAA) PT Lowered to $16 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
